Adherencia a los tratamientos biológicos: un equilibrio entre necesidad y preocupación

Mónica Vázquez-Díaz; Javier Bachiller-Corral

doi:10.7399/fh.11289

Adherencia a los tratamientos biológicos: un equilibrio entre necesidad y preocupación

Mónica Vázquez-Díaz, Javier Bachiller-Corral

Resumen

Palabras clave

Texto completo:

PDF (English) PDF

Referencias

World Health Organisation. Adherence to long-term therapies: evidence for action. Geneva: World Health Organisation; 2003.

Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-67.

Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633. DOI: 10.1371/journal.pone.0080633

National Institute for Health and Clinical Excellence. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence CG76. London: National Institute for Health and Clinical Excellence; 2009.

Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269-76.

Calleja MA, Herrero A, Lamas MJ, Martínez J, Poveda JL, Aragón B. Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data. Farm Hosp. 2017;41(1):31- 48.

Tkacz J, Ellis L, Bolge SC, Meyer R, Brady BL, Ruetsch C. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients. Clin Ther. 2014;6:737-47.

Bhoi P, Bessette L, Bell MJ, Tkaczyk C, Nantel F, Maslova K. Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database. BMJ Open. 2017:7(9):e015872. DOI: 10.1136/bmjopen-2017-015872

Martínez-López de Castro N, Álvarez-Payero M, Samartín-Ucha M, Martín-Vila A, Piñeiro-Corrales G, Pego Reigosa JM, Working Group IRIDIS. Adherence to biological therapies in patients with chronic inflammatory arthropathies. Farm Hosp. 2019;43(3):134- 139.

Zwikker HE, van Dulmen S, den Broeder AA, van den Bemt BJ, van den Ende CH. Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Prefer Adherence. 2014;8:1635-45.

Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, et al. Comparing patient-perceived and physician- perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. Ann Rheum Dis. 2019;78:201-8.

Margusino-Framiñán L, Cid-Silva P, Martínez-Roca C, García- Queiruga M, Fernández-Gabriel E, Mateos-Salvador M, et al. Implementation of specialized pharmaceutical care hospital outpatient clinics in a hospital pharmacy department. Farm Hosp. 2017;41(6):660-6.

Montori VM, Brito JP, Murad MH. The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA. 2013; 310(23):2503-4.

DOI: http://dx.doi.org/10.7399%2Ffh.11289